MEXICO – The Novartis pharmaceutical company reported that authorization was obtained from health officials to sell a drug to combat metastatic breast cancer (that extends to other parts of the body), which would allow a survival of up to five years.
In a press conference the general director of Novartis Oncology, Miguel Gallero, and medical specialists, highlighted the benefits of this drug that obtained the sanitary registry in November and will be available in the first third of 2018.
Gallero informed that Novartis invested nine billion dollars in 2016, worldwide, to promote the research of various molecules to continue the development of innovative medicines, such as the one called Ribociclib.
He added that precisely with the support of these innovative medicines, treatments are offered that give hope to patients to extend their life with quality, even to incorporate them into their daily tasks.
He indicated that 60% to 80 % of metastatic cancer in Mexico is diagnosed in locally advanced stages, however, with the application of new treatments, 81% of patients in stage four, which is among the most advanced, achieves five-year survival.
Meanwhile, the medical director of Novartis Oncology, Guillermina Muñoz, said that the treatments that this international laboratory has developed have revolutionized the context of patients with metastatic breast cancer in the world.
She highlighted that by doing research on the molecule that gives rise to Ribociclib, the increase, almost double, of progression-free survival, which allows a better quality of life, was demonstrated.
She explained that after two years of treatment, the combination of Ribociclib plus Letrozole increased the percentage of progression-free survival to 54.7%, compared with 35.9% in patients treated only with Letrozole.
The psychologist Alejandra Platas, of the Doctors and Researchers Foundation in the Fight against Breast Cancer (MILC), pointed out that 50 percent of the cases of advanced cancer in Mexico do not receive treatment when they face chronic pain, reason why she considered that it requires more prevention actions.
more recommended stories
North American companies see investment opportunities in Yucatan
As of June 25, Courtney Beale.
Lobster production declines in the coast of Yucatán
Three weeks after the lobster harvest.
X’ocen: a rural community where Maya ancestral ceremonies still very much alive
X’ocen is a pre-Hispanic sanctuary, and.
Oil auctions in Mexico postponed until February
According to REUTERS, Mexican oil auctions.
Zapatista rebels reject meeting with López Obrador
Mexico’s leftist President-elect Andres Manuel Lopez.
Municipal crews work 24/7 to keep sargassum off the beach in Cancun
“The cleaning works carried out since.
Yucatecan enterpreneurs seek to strengthen local productivity with “Tech Day”
In order to strengthen partnerships, and.
Catalog highlights relevance of the flower in Mexican Culture
The flower, addressed as a substantive.
19th edition of the International Jazz Festival of Campeche features world-class artists
Campeche will present its International Jazz.
PEMEX pipeline on the Mérida-Progreso highway explodes as fuel was being illegaly extracted
According to unofficial reports, the explosion.